Please Wait.....
Report
Germany Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 97 Pages I Mordor Intelligence
Germany Drug Delivery Devices Market Analysis
The Germany drug delivery devices market is valued at USD 10.45 billion in 2025 and is forecast to reach USD 15.90 billion by 2030, registering an 8.75% CAGR. Continuous gains stem from the country's broad statutory insurance coverage, strong manufacturing base in high-value syringes and autoinjectors, and an expanding pipeline of biologics that require precise administration technologies. High diabetes prevalence, a rising cancer burden, and Germany's well-resourced hospital network keep demand for injectable systems elevated, while rapid shifts toward home-based care and sustainability goals are opening space for connected, reusable formats. EU-wide joint clinical assessments introduced in 2025, domestic fast-track pathways, and real-time digital adherence tools together shorten launch timelines and support uptake of next-generation devices, even as reference-price rules temper premium options.
Germany Drug Delivery Devices Market Trends and Insights
High Prevalence and Incidence of Chronic and Infectious Diseases
Germany reports higher-than-EU-average prevalence for diabetes (8.4%), cardiovascular diseases (6.8%), and chronic respiratory diseases (11.4%). This chronic-disease load drives steady demand for advanced injectors, insulin pens, smart pumps, and sustained-release implants that improve adherence and outcomes. Diabetes alone is projected to affect 10.9-14.2 million Germans by 2040, pushing continuous upgrades in automated insulin delivery ecosystems. Oncology demand follows a similar path: micro-/nano-robots under development at the German Cancer Research Center aim to raise tumour-site uptake while cutting systemic toxicity. Together, disease trends and research breakthroughs keep the Germany drug delivery devices market on an innovation-driven trajectory.
Growing Trend of Home Healthcare and Aging Population
People aged ? 65 will rise from 21% of the population in 2023 to nearly 30% by 2050. Concurrently, those requiring long-term care could climb to 14 million by 2050. These shifts amplify the need for devices that non-professionals can use safely in domestic settings. On-body injectors such as Gerresheimer's Gx SensAir allow weekly subcutaneous dosing of monoclonal antibodies without clinical visits, cutting travel-related emissions and easing caregiver burdens. Consumer familiarity with telehealth platforms further accelerates uptake of connected inhalers, pens, and patches that integrate adherence dashboards, reinforcing market momentum in Germany drug delivery devices market.
Stringent Regulatory Requirements and Product Recalls
Germany enforces EU Medical Device Regulation (MDR) alongside its Medical Device Law Implementation Act. Combination products must satisfy dual drug-device evidence packages, and higher-risk classes require third-party conformity assessments.Resulting cost spikes and recall liabilities weigh heaviest on SMEs, occasionally pausing launches and trimming the Germany drug delivery devices market growth curve.
Other drivers and restraints analyzed in the detailed report include:
Increasing Investment in Biosimilar and Biologics Product Innovation and Development / Government Initiatives Supporting Fast Track Approval and Reimbursement / /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Injectable devices represented 43.45% of all revenues in 2024, cementing their role in the Germany drug delivery devices market size. Sustained demand arises from biologic therapies that dominate new drug approvals and from continuing preference among clinicians for parenteral accuracy. SCHOTT Pharma's capacity surge in polymer and glass syringes underscores industry confidence.
Implantable pumps, micro-chips, and bioresorbable depots post the quickest gains at an 10.24% CAGR. Patient-friendly inhalers preserve share amid a high national burden of chronic respiratory illness, while transdermal patches earn incremental adoption for hormone and pain management. Across categories, embedded connectivity features enhance dose logging and feedback loops, lifting adherence and data-driven care pathways within the Germany drug delivery devices market.
Injectable delivery retained a 49.67% revenue stake in 2024, reflecting clinician trust in intravenous, subcutaneous, and intramuscular routes for vaccines and large-molecule drugs. This proportion anchors the Germany drug delivery devices market share and is bolstered by next-gen autoinjectors that lower activation force and support 2-5 mL volumes.
Transdermal formats scale fastest at a 10.03% CAGR on the back of microneedle arrays and wirelessly powered acoustic patches that raise payload size limits. Oral mucosal films gain traction for rapid pain relief, while inhaled, ocular, and nasal modalities extend options for targeted local therapy, together enriching clinical toolkits available to practitioners in the Germany drug delivery devices market.
Germany Drug Delivery Devices Market Report is Segmented by Device Type (Injectable Delivery Devices, Transdermal Patches, Infusion Pumps, and More), Route of Administration (Injectable, Inhalational, Transdermal, and More), Application (Diabetes, Oncology, Cardiovascular, and More), and End Users (Hospitals, Ambulatory Surgical Centres, Homecare Settings, and More). The Market and Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Beckton Dickinson / Gerresheimer / Ypsomed / Bayer / Boehringer Ingelheim / Pfizer / Solventum / Phillips-Medisize LLC / Novartis / Owen Mumford / Novo Nordisk / Medtronic / West Pharmaceutical Services / SCHOTT / Haselmeier GmbH / Sanofi / Terumo / Teva Pharmaceutical Industries / Vetter Pharma-Fertigung GmbH & Co. KG / Nemera La Verpilliere SAS /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence and Incidence of Chronic and Infectious Diseases
4.2.2 Growing Trend of Home Healthcare and Aging Population
4.2.3 Increasing Investment in Biosimiliar and Biologics Product Innovation and Development
4.2.4 Government Initiatives Supporting Fast Track Approval and Reimbursemnet
4.2.5 Technological Advancement and Digitalization
4.2.6 Expansion of Contract-Manufacturing Hubs
4.3 Market Restraints
4.3.1 Stringent Regulatory Requirements and Product Recalls
4.3.2 G-BA Price Regulation Capping Premiums for Innovative Systems
4.3.3 Market Saturation in Conventional systems Coupled with Patient Compliance and Acceptance Issues
4.3.4 Limited Availability of Specialized Microfluidics & Combination-Product Engineering Talent
4.4 Value / Supply-Chain Analysis
4.5 Regulatory and Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Bargaining Power of Suppliers
4.6.2 Bargaining Power of Buyers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size and Growth Forecasts (Value-USD)
5.1 By Device Type
5.1.1 Injectable Delivery Devices
5.1.2 Inhalation Delivery Devices
5.1.3 Infusion Pumps
5.1.4 Transdermal Patches
5.1.5 Implantable Drug Delivery Systems
5.1.6 Ocular Inserts & Delivery Implants
5.1.7 Nasal & Buccal Delivery Devices
5.2 By Route of Administration
5.2.1 Injectable
5.2.2 Inhalation
5.2.3 Transdermal
5.2.4 Oral Mucosal (Buccal and Sublingual)
5.2.5 Ocular
5.2.6 Nasal
5.3 By Application
5.3.1 Diabetes
5.3.2 Oncology
5.3.3 Cardiovascular
5.3.4 Respiratory
5.3.5 Central Nervous System Disorders
5.3.6 Infectious Diseases
5.3.7 Others
5.4 By End-user
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centres
5.4.3 Homecare Settings
5.4.4 Clinics and Speciality Centres
5.4.5 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Becton, Dickinson and Company
6.4.2 Gerresheimer AG
6.4.3 Ypsomed Holding AG
6.4.4 Bayer AG
6.4.5 Boehringer Ingelheim International GmbH
6.4.6 Pfizer Inc.
6.4.7 Solventum
6.4.8 Phillips-Medisize LLC
6.4.9 Novartis AG
6.4.10 Owen Mumford Ltd
6.4.11 Novo Nordisk A/S
6.4.12 Medtronic plc
6.4.13 West Pharmaceutical Services Inc.
6.4.14 SCHOTT AG
6.4.15 Haselmeier GmbH
6.4.16 Sanofi S.A.
6.4.17 Terumo Corporation
6.4.18 Teva Pharmaceutical Industries Ltd.
6.4.19 Vetter Pharma-Fertigung GmbH & Co. KG
6.4.20 Nemera La Verpilliere SAS
7 Market Opportunities and Future Outlook
7.1 White-Space and Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security